Y Intercept Hong Kong Ltd Invests $368,000 in AVANOS MEDICAL, INC. (NYSE:AVNS)

Key Points

• Y Intercept Hong Kong Ltd has acquired 25,700 shares of Avanos Medical, valued at approximately $368,000, making up about 0.06% of the company's total shares.
• Avanos Medical's stock has seen a 12-month low of $11.21 and a high of $25.36, currently trading at $11.81; the company reported earnings of $0.26 per share last quarter, exceeding analysts' expectations.
• Institutional investors and hedge funds currently own 95.17% of Avanos Medical's stock, indicating significant institutional interest in the company.

Y Intercept Hong Kong Ltd purchased a new position in AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 25,700 shares of the company's stock, valued at approximately $368,000. Y Intercept Hong Kong Ltd owned 0.06% of AVANOS MEDICAL at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in AVNS. GAMMA Investing LLC increased its stake in shares of AVANOS MEDICAL by 2,381.6% during the 1st quarter. GAMMA Investing LLC now owns 17,024 shares of the company's stock worth $244,000 after purchasing an additional 16,338 shares during the last quarter. Bank of America Corp DE increased its stake in shares of AVANOS MEDICAL by 2.5% during the 4th quarter. Bank of America Corp DE now owns 63,672 shares of the company's stock worth $1,014,000 after purchasing an additional 1,537 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of AVANOS MEDICAL by 2.6% during the 1st quarter. Principal Financial Group Inc. now owns 244,063 shares of the company's stock worth $3,497,000 after purchasing an additional 6,269 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of AVANOS MEDICAL by 15.8% during the 4th quarter. Envestnet Asset Management Inc. now owns 128,567 shares of the company's stock worth $2,047,000 after purchasing an additional 17,504 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of AVANOS MEDICAL by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company's stock worth $85,009,000 after purchasing an additional 19,476 shares during the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.

AVANOS MEDICAL Stock Performance

Shares of NYSE AVNS traded down $0.18 during trading hours on Friday, hitting $11.00. 670,789 shares of the stock were exchanged, compared to its average volume of 502,735. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.57 and a quick ratio of 1.56. The company's 50 day moving average is $12.16 and its 200 day moving average is $13.66. The firm has a market capitalization of $508.41 million, a P/E ratio of -1.31 and a beta of 1.12. AVANOS MEDICAL, INC. has a one year low of $10.86 and a one year high of $25.36.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a negative net margin of 55.80% and a positive return on equity of 6.26%. The firm had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. During the same period in the prior year, the firm earned $0.22 EPS. The business's revenue was up .8% on a year-over-year basis. On average, research analysts expect that AVANOS MEDICAL, INC. will post 1.32 EPS for the current year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.